Survival analysis in familial ovarian cancer, a case control study
- 1 October 2001
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 98 (2) , 219-223
- https://doi.org/10.1016/s0301-2115(01)00318-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Ovarian cancer incidence (1989–1991) and mortality (1954–1993) in the NetherlandsPublished by Wolters Kluwer Health ,1999
- Quantification of p53 in Epithelial Ovarian CancerGynecologic Oncology, 1997
- Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.Journal of Clinical Oncology, 1997
- Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: Its importance in long-term survivalAmerican Journal of Obstetrics and Gynecology, 1996
- Clear Cell Carcinoma of the Ovary: A Distinct Histologic Type with Poor Prognosis and Resistance to Platinum-Based Chemotherapy in Stage III DiseaseGynecologic Oncology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- An evaluation of prognostic factors in advanced ovarian cancerEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1995
- Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: A prospective studyAmerican Journal of Obstetrics and Gynecology, 1994
- Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapseAmerican Journal of Obstetrics and Gynecology, 1993
- Improved prognosis of ovarian cancer in The Netherlands during the period 1975–1985: A registry-based studyGynecologic Oncology, 1991